TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18583285

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) 300 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 300 mg/day + Clopidogrel 75 mg/day
Number of subjects: 60
Study: 16567982

Group type: EXPERIMENTAL
Intervention: 2 doses of 9VPCV
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1 dose of 9VPCV
Number of subjects: 0
Study: 14576714

Group type: EXPERIMENTAL
Intervention: Video lessons (self-administered, video-lesson packets)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Traditional lessons (face-to-face sessions)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both groups (Video Group and Traditional Group)
Number of subjects: 93
Study: 11089626

Group type: EXPERIMENTAL
Intervention: Circumcision
Number of subjects: 5507

Group type: EXPERIMENTAL
Intervention: Prepubertal circumcision
Number of subjects: 5507

Group type: EXPERIMENTAL
Intervention: Circumcision in HIV-positive men with viral loads <50,000 copies/ml
Number of subjects: 5507
Study: 8721244

Group type: EXPERIMENTAL
Intervention: 0.4% Sumithrine
Number of subjects: 4

Group type: COMPARATOR
Intervention: 1% Lindane
Number of subjects: 4
Study: 1333181

Group type: EXPERIMENTAL
Intervention: 1 mg subcutaneous sumatriptan
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: 2 mg subcutaneous sumatriptan
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: 3 mg subcutaneous sumatriptan
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: 4 mg subcutaneous sumatriptan
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: 6 mg subcutaneous sumatriptan
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: 8 mg subcutaneous sumatriptan
Number of subjects: 242

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study: 3881206

Group type: EXPERIMENTAL
Intervention: timolol, 1 mg iv, followed by 1 mg doses at 20-min intervals
Number of subjects: 160

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: timolol
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: timolol for paroxysmal supraventricular tachycardia
Number of subjects: 160

Group type: COMPARATOR
Intervention: placebo for paroxysmal supraventricular tachycardia
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: timolol for atrial fibrillation
Number of subjects: 160

Group type: COMPARATOR
Intervention: placebo for atrial fibrillation
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: timolol for atrial flutter
Number of subjects: 160

Group type: COMPARATOR
Intervention: placebo for atrial flutter
Number of subjects: 160
Study: 30329105

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Number of subjects: 172
Study: 29453622

Group type: EXPERIMENTAL
Intervention: OA intervention group (12-month phone-based patient behavioral protocol including weight management, physical activity, and cognitive-behavioral pain management)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 300
Study: 26663636

Group type: EXPERIMENTAL
Intervention: Manipulating the rank position of tooth-brushing duration in Study 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Messages relating to rank positions of tooth-brushing durations in Study 3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-reported attitudes, cognitions, and behavior towards tooth-brushing duration in Studies 1 and 2
Number of subjects: 0
Study: 24655473

Group type: EXPERIMENTAL
Intervention: Electronic cigarette
Number of subjects: 0
Study: 22735462

Group type: EXPERIMENTAL
Intervention: Sugammadex 4 mg/kg
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Sugammadex 32 mg/kg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg (positive control)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 20445768

Group type: EXPERIMENTAL
Intervention: WALC‐S intervention
Number of subjects: 97

Group type: COMPARATOR
Intervention: Time-and-attention control (TAC)
Number of subjects: 97
Study: 17660871

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temsirolimus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 0
Study: 16309053

Group type: EXPERIMENTAL
Intervention: Deep needling group (acupuncture at local acupoints and deeply needling at local acupoints to nerve stem for 3 courses)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine needling group (shallow acupuncture at local acupoints and distal acupoints along the Hand and Foot‐Yangming Channels)
Number of subjects: 90
Study: 11923548

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (FP) 750 microg bd
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 9797055

Group type: EXPERIMENTAL
Intervention: Sonic toothbrush
Number of subjects: 31

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 31
Study: 8596749

Group type: EXPERIMENTAL
Intervention: rHuEPO therapy for 12 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: No treatment (No-EPO group)
Number of subjects: 20
Study: 2650482

Group type: EXPERIMENTAL
Intervention: Color-flow Doppler
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional duplex scanning
Number of subjects: 74
Study: 786961

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (400 mcg/day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 31015318

Group type: EXPERIMENTAL
Intervention: Intraincisional ropivacaine (0.2%)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Intraperitoneal ropivacaine (0.2%)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Combined intraincisional and intraperitoneal ropivacaine (0.2%)
Number of subjects: 191
Study: 27998692

Group type: EXPERIMENTAL
Intervention: Squill Oxymel (10ml syrup, 2 times a day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Simple oxymel (10ml syrup, 2 times a day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 25787895

Group type: EXPERIMENTAL
Intervention: DC loaded with recombinant Prostate Specific Membrane Antigen (rPSMA) and recombinant Survivin (rSurvivin) peptides administered as a subcutaneous (s.c.) injection (5×10(6) cells)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m(2) intravenous (i.v.)) and prednisone (5 mg, bis in die (b.i.d.))
Number of subjects: 21
Study: 23676938

Group type: EXPERIMENTAL
Intervention: Eating behavior intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional health care
Number of subjects: 0
Study: 21827648

Group type: EXPERIMENTAL
Intervention: Supervised walks of 30 minutes a day, 5 days a week as part of daily nursing care.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sedentary activities (tea or other activities) three times a week.
Number of subjects: 0
Study: 19413409

Group type: EXPERIMENTAL
Intervention: Cigarette smoking satisfaction
Number of subjects: 394

Group type: COMPARATOR
Intervention: Patch treatment for smoking cessation
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Cigarette smoking in positive moods
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Intensity of craving prior to smoking
Number of subjects: 394
Study: 17270294

Group type: EXPERIMENTAL
Intervention: Caucasian subjects
Number of subjects: 248
Study: 14517190

Group type: EXPERIMENTAL
Intervention: Rofecoxib 12.5 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 11188492

Group type: EXPERIMENTAL
Intervention: Daily positive and negative affect
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Daily nonwork events (positive and negative)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Daily work events (positive and negative)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Negative work events
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Lifetime symptoms of alcohol dependence and treatment condition
Number of subjects: 46
Study: 9195351

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg i.v. propofol bolus followed by a continuous 0.5 mg/kg/hr infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: 5% dextrose solution
Number of subjects: 40
Study: 1540108

Group type: EXPERIMENTAL
Intervention: Mild aversive stimulus (bitter substance painted on nails)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Competing response therapy (performing a competing response when the urge to bite occurs)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Self-monitoring alone
Number of subjects: 21
Study: 2870990

Group type: EXPERIMENTAL
Intervention: Nifedipine combined with propranolol (80 mg twice daily)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nifedipine combined with betaxolol (20 mg once daily)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Propranolol alone (80 mg twice daily)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Betaxolol alone (20 mg once daily)
Number of subjects: 6
Study: 31755587

Group type: EXPERIMENTAL
Intervention: S‐ibuprofen
Number of subjects: 22

Group type: COMPARATOR
Intervention: R‐ibuprofen
Number of subjects: 22

Group type: COMPARATOR
Intervention: Achiral method
Number of subjects: 22
Study: 27872384

Group type: EXPERIMENTAL
Intervention: Happy Being Me ‐ Appearance Comparison
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Happy Being Me ‐ Media Literacy
Number of subjects: 260

Group type: COMPARATOR
Intervention: Happy Being Me ‐ Healthy Eating Behaviour
Number of subjects: 260
Study: 28050987

Group type: EXPERIMENTAL
Intervention: Local anesthesia with adrenaline
Number of subjects: 100

Group type: COMPARATOR
Intervention: Local anesthesia without adrenaline
Number of subjects: 100
Study: 27031099

Group type: EXPERIMENTAL
Intervention: Biweekly acupuncture treatments for 6 months (group 1)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Weekly acupuncture treatments after 2 months of waitlist (group 2)
Number of subjects: 104
Study: 25457926

Group type: EXPERIMENTAL
Intervention: Multidimensional Treatment Foster Care (MTFC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 100
Study: 23058022

Group type: EXPERIMENTAL
Intervention: Hypertonic saline (2.7% sodium chloride solution), administered twice-daily using a disposable 20 ml syringe for 4 weeks
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Normal saline, administered twice-daily using a disposable 20 ml syringe for 4 weeks
Number of subjects: 220

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 220
Study: 19534034

Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control (Education Program)
Number of subjects: 86
Study: 17300595

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg q.d.
Number of subjects: 1172

Group type: COMPARATOR
Intervention: Glipizide 5 mg/day (uptitrated to a maximum of 20 mg/day)
Number of subjects: 1172
Study: 15286110

Group type: EXPERIMENTAL
Intervention: Tooth Morphology (computer-assisted learning program)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Lecture (traditional lecture)
Number of subjects: 45
Study: 11142674

Group type: EXPERIMENTAL
Intervention: PerioChip (chlorhexidine gluconate 2.5 mg)
Number of subjects: 26
Study: 11189161

Group type: EXPERIMENTAL
Intervention: Predforte (10% prednisolone acetate) administered transnasally to the operative cavity
Number of subjects: 75
Study: 7706104

Group type: EXPERIMENTAL
Intervention: Dextrose-saline solution containing 1 IU per ml of heparin
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control solutions (without heparin)
Number of subjects: 80
Study: 2618526

Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing (Comfeel Ulcus) in Group 1
Number of subjects: 58

Group type: COMPARATOR
Intervention: Compression stockings in Group 2
Number of subjects: 58

Group type: COMPARATOR
Intervention: Group 2 (serum levels of iron, zinc, copper, selenium measured)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Group 1 (3 mm punch biopsy for histopathological examination)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Group 2 (temperature difference measurement)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Group 2 (ulcer pH measurement)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Group 2 (serum levels comparison)
Number of subjects: 58
Study: 908352

Group type: EXPERIMENTAL
Intervention: Frank lead vectorcardiogram (VCG), orthogonal electrocardiogram (ECG), and standard scalar ECG measurements in 78 patients
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Validation of the regression equation in 34 patients
Number of subjects: 112
Study: 30746976

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR) with morphine 0.15 mg/kg daily in divided doses
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group with morphine 0.15 mg/kg daily in divided doses
Number of subjects: 70
Study: 28806791

Group type: EXPERIMENTAL
Intervention: Open book (UpToDate) with typical time
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Open book (UpToDate) with additional time
Number of subjects: 825

Group type: COMPARATOR
Intervention: Closed book with typical time
Number of subjects: 825

Group type: COMPARATOR
Intervention: Closed book with additional time
Number of subjects: 825

Group type: COMPARATOR
Intervention: Closed book conditions
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Open book conditions
Number of subjects: 825
Study: 25253432

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1 mA, 15 min)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (1 mA, 15 min)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Paired F-VEPs
Number of subjects: 26
Study: 23905554

Group type: EXPERIMENTAL
Intervention: Intra-operative iv administration of fluid boluses based on stroke volume measured by oesophageal Doppler (probe arm)
Number of subjects: 74

Group type: COMPARATOR
Intervention: iv fluid based on clinical indicators (no-probe arm)
Number of subjects: 74
Study: 21919372

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (0.125 mg/kg) plus clonidine (0.5 microg/kg)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Intravenous placebo (sodium chloride 0.9%)
Number of subjects: 68
Study: 19826560

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg) as add-on to standard treatment for alcohol dependence
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard treatment for alcohol dependence without sildenafil
Number of subjects: 108
Study: 16419069

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (AC)
Number of subjects: 350
Study: 15280526

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion (20 mU/min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: dDAVP (2 micro g subcutaneously)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no oxytocin or dDAVP)
Number of subjects: 20
Study: 11343530

Group type: EXPERIMENTAL
Intervention: Supportive-expressive group therapy for 1 year
Number of subjects: 125

Group type: COMPARATOR
Intervention: Educational materials only (Control)
Number of subjects: 125
Study: 9217118

Group type: EXPERIMENTAL
Intervention: Carbon dioxide laser
Number of subjects: 98

Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 98
Study: 8488748

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 59

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 59
Study: 6601445

Group type: EXPERIMENTAL
Intervention: Hexabrix
Number of subjects: 51

Group type: COMPARATOR
Intervention: Renografin 60
Number of subjects: 51
Study: 31537527

Group type: EXPERIMENTAL
Intervention: Plerixafor (400 μg/kg/day) infused intravenously for 4 consecutive weeks starting at day 35 of concurrent chemoradiation.
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Plerixafor (400 μg/kg/day)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: MRI and histopathology analysis
Number of subjects: 29
Study: 29748109

Group type: EXPERIMENTAL
Intervention: rasagiline 1 mg/day
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: rasagiline 0.5 mg/day
Number of subjects: 404

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 404
Study: 27358154

Group type: EXPERIMENTAL
Intervention: lipid-lowering nutraceutical
Number of subjects: 80
Study: 25150911

Group type: EXPERIMENTAL
Intervention: Pre-meal video game playing (VGP) for 30 minutes
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Glucose preload (50g in 250mL of water)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No pre-meal video game playing (no-VGP)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Non-caloric sucralose control
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Subjective appetite measured at 0, 15, 30, and 60 minutes
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Frustration and aggression scores after VGP
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Baseline and pre-meal happiness and excitement scores
Number of subjects: 19
Study: 21971943

Group type: EXPERIMENTAL
Intervention: GB-0998 (high-dose intravenous immunoglobulin therapy)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 19204077

Group type: EXPERIMENTAL
Intervention: Exercise on prescription intervention
Number of subjects: 1089

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1089
Study: 17949325

Group type: EXPERIMENTAL
Intervention: Extraperitoneal approach
Number of subjects: 62

Group type: COMPARATOR
Intervention: Transperitoneal approach
Number of subjects: 62
Study: 16786813

Group type: EXPERIMENTAL
Intervention: Facial electromyography (EMG) method
Number of subjects: 32

Group type: COMPARATOR
Intervention: Healthy subjects (control)
Number of subjects: 32
Study: 15300236

Group type: EXPERIMENTAL
Intervention: CSP and MMF
Number of subjects: 40

Group type: COMPARATOR
Intervention: CSP and MTX
Number of subjects: 40
Study: 10812286

Group type: EXPERIMENTAL
Intervention: Marijuana (3.55% Delta(9)-THC)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo (0% THC)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Naltrexone (0, 50, or 200 mg)
Number of subjects: 5
Study: 8966499

Group type: EXPERIMENTAL
Intervention: SYSTEN 50
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MENOREST 50
Number of subjects: 30
Study: 1854464

Group type: COMPARATOR
Intervention: DuP 753 (2.5, 5, 10, 20, and 40 mg single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: DuP 753 (5, 10, 20, or 40 mg multiple dose, once daily for eight days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (single and multiple doses)
Number of subjects: 0
Study: 6396118

Group type: EXPERIMENTAL
Intervention: Bifonazole 1% cream
Number of subjects: 29

Group type: COMPARATOR
Intervention: Bifonazole cream vehicle
Number of subjects: 29
Study: 31162858

Group type: EXPERIMENTAL
Intervention: Targeted mild hypothermia in organ donors after neurologic determination of death
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard donor management practice using static cold storage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted mild hypothermia
Number of subjects: 0
Study: 28877011

Group type: EXPERIMENTAL
Intervention: Tezepelumab 70 mg every 4 weeks
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Tezepelumab 210 mg every 4 weeks
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Tezepelumab 280 mg every 2 weeks
Number of subjects: 584

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 584
Study: 25741666

Group type: EXPERIMENTAL
Intervention: Telemedicine (n = 296)
Number of subjects: 567

Group type: COMPARATOR
Intervention: Traditional surveillance (n = 271)
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Telemedicine (n = 409 participants total after offering to both groups)
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Telemedicine (n = 271 to 208 participants)
Number of subjects: 567
Study: 22989326

Group type: EXPERIMENTAL
Intervention: Accumulated brisk walking programme (15 min in the morning and afternoon, at least three times a week for 15 weeks)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual school day activities (Control)
Number of subjects: 152
Study: 21298236

Group type: EXPERIMENTAL
Intervention: Periarticular infiltration with triamcinolone acetonide, bupivacaine and epinephrine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bupivacaine and epinephrine (Control)
Number of subjects: 100
Study: 19339704

Group type: EXPERIMENTAL
Intervention: Fish oil and isoflavone placebo (FO)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fish oil placebo and isoflavones (ISO)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fish oil placebo and isoflavone placebo (placebo)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fish oil and isoflavones (FO + ISO)
Number of subjects: 10
Study: 16737850

Group type: EXPERIMENTAL
Intervention: Aspirin 325mg
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 15201716

Group type: EXPERIMENTAL
Intervention: PMMA lens
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fenestrated lens
Number of subjects: 10
Study: 11153782

Group type: EXPERIMENTAL
Intervention: Group learning program based on personal construct theory (12 meetings, 4 hours every 2 weeks from February 1997 to October 1997)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 116
Study: 9432316

Group type: EXPERIMENTAL
Intervention: Omeprazole plus amoxicillin treatment regimen
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: H. pylori eradication assessment at 1 month posttreatment
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Overall efficiency of H. pylori tests
Number of subjects: 384
Study: 8384171

Group type: EXPERIMENTAL
Intervention: Group counselling (GC group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Individual counselling (IC group)
Number of subjects: 60
Study: 3811804

Group type: EXPERIMENTAL
Intervention: Fentanyl 0.002 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl 0.004 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no fentanyl)
Number of subjects: 60
Study: 30075898

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.5 µg/kg/h) during cardiopulmonary bypass
Number of subjects: 70

Group type: COMPARATOR
Intervention: Propofol continuous intravenous infusion (50 to 70 µg/kg/min)
Number of subjects: 70